Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients-A Retrospective Observational Study.Cancers · 2022
   Article
2. Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma.Medicine · 2020
   Article
3. Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma.Frontiers in oncology · 2020
   Article
4. Paris polyphylla 26 triggers G2/M phase arrest and induces apoptosis in HepG2 cells via inhibition of the Akt signaling pathway.The Journal of international medical research · 2019
   Article
5. Hepatocellular carcinoma: early-stage management challenges.Journal of hepatocellular carcinoma · 2017
   Review
6. Controversies and evidence of hepatic resection for hepatocellular carcinoma.BBA clinical · 2016
   Review
7. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.Clinical and molecular hepatology · 2016
   Article
8. A premature proposal for new liver cancer seromarkers.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
   Article
9. Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma.Medicine · 2016
   Article
10. Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma.Medicine · 2015
    Observational
11. Intermediate-stage HCC--upfront resection can be feasible.Nature reviews. Clinical oncology · 2015
    Article
12. Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery.Nature reviews. Clinical oncology · 2015
    Article
13. Nucleos(t)ide analogue therapy for HBV-related HCC after hepatic resection: clinical benefits and unanswered questions.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as